Back to search

Article

Immunization by exposure to live virus (SIV <sub>mne</sub> /HIV-2 <sub>287</sub> ) during antiretroviral drug prophylaxis reduces risk of subsequent viral challenge

2020-10-01

Abstract excerpt

<h4>Rationale/Study Design</h4> A major challenge in the development of HIV vaccines is finding immunogens that elicit protection against a broad range of viral strains. Immunity to a narrow range of viral strains may protect infants of HIV-infected women or partners discordant for HIV. We hypothesized that immunization to the relevant viral variants could be achieved by exposure to infectious virus during prophy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
49f9e4bc-b5e0-509d-9101-d45c64c7fc78
DOI
10.1101/2020.09.30.320820
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunization by exposure to live virus (SIV <sub>mne</sub> /HIV-2 <sub>287</sub> ) during antiretroviral drug prophylaxis reduces risk of subsequent viral challengeDOI 10.1101/2020.09.30.320820
Select a neighboring publication to make it the new centre.